Skip to main content
. 2021 Nov 24;14(12):1216. doi: 10.3390/ph14121216

Figure 2.

Figure 2

The 3D docked poses of SARS-CoV-2 Mpro-bioactive compounds, namely natural products: (a) licuraside, (b) glucoliquiritin apioside, (c) 7,3′-Dihydroxy-5′-methoxyisoflavone, (d) licuroside, (e) glycyrrhizin, displaying the change in ligand conformation in the active pocket of SARS-CoV-2 Mpro during a 100 ns MD simulation interval.